eng1.gif (176 bytes)

Russian Journal

ISSN 0042-8809

 

Biomeditsinskaya Khimiya

Biomedical Chemistry


Home  ׀  Editorial Board ׀  International Advisory Board  ׀  Aim and Scope ׀   Contents and Abstracts  ׀  Information for Authors ׀  Subscribe Now


Issue: Volume 54, issue 2

Title: CYSTATINS: CYSTEINE PROTEASES REGULATION AND DISTURBANCES IN TUMORS AND INFLAMMATION.

 

Authors: T.A. Korolenko1, T.G. Filatova1, M.S. Cherkanova2, T.A. Khalikova1, I.Yu. Bravve2.

 

Address:

1. Institute of Physiology Siberian Branch of Russian Academy of Medical Sciences, Timakov str., 4, Novosibirsk, 630117 Russia;

2. Novosibirsk Regional Cardiology Unit, Novosibirsk, 630099 Russia; e-mail: T.A.Korolenko@iph.ma.nsc.ru.

 Abstract:

Cystatin C belongs to the group of wide spread extracellular cysteine protease inhibitors. Using ELISA kits it was shown that the highest cystatin C concentration was in human cerebrospinal fluid and low cystatin C concentration was in human urine. In healthy young persons serum cystatin C concentration was lower than in elder patients (50-65 year old). In patients with hemoblastoses (lymphoma, lymphogranulomatosis) increased serum cystatin C concentration was normalized after effective antitumor therapy. According to these data one can conclude that serum cystatin C concentration can be used as one of the prognostic criteria in patients with several kinds of hemoblastoses.

Key words: cystatins, cysteine proteases, tumors, atherosclerosis.

 


[Back]